1. Home
  2. BNR vs PDSB Comparison

BNR vs PDSB Comparison

Compare BNR & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$23.40

Market Cap

216.9M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.99

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
PDSB
Founded
2014
2005
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.9M
49.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
PDSB
Price
$23.40
$0.99
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
54.2K
563.8K
Earning Date
11-20-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$75,749,382.00
N/A
Revenue This Year
$136.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.56
N/A
52 Week Low
$2.18
$0.70
52 Week High
$24.92
$2.20

Technical Indicators

Market Signals
Indicator
BNR
PDSB
Relative Strength Index (RSI) 58.13 61.39
Support Level $19.10 $0.76
Resistance Level $24.92 $0.93
Average True Range (ATR) 2.36 0.06
MACD -0.02 0.01
Stochastic Oscillator 67.01 82.64

Price Performance

Historical Comparison
BNR
PDSB

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: